Tuoxin Pharmaceutical group Co., Ltd

Tuoxin Pharmaceutical Group Co., Ltd. (hereinafter referred to as the Group) is a high-tech enterprise that integrates the research and development, production, and sales of chemical synthesis, biological fermentation nucleoside (acid) raw materials, and pharmaceutical intermediates. It has strong capabilities in the research and production of nucleoside (acid) raw materials and pharmaceutical intermediates in China. The group has advantages in the research and development of domestic nucleoside (acid) raw materials and pharmaceutical intermediates, such as early start, large scale, and complete variety, and has formed a relatively complete ladder product chain from basic products to high-end products. The group aims to build an efficient catalytic synthesis reaction technology platform, nucleoside fermentation technology platform, and biotransformation semi synthesis technology platform; And it has formed multiple series of nucleoside (acid) products, including pyrimidine series, purine series, nucleotide series, nucleoside series, etc., including active pharmaceutical ingredients such as cytidine sodium, ribavirin, inosine, cytosine, 5-fluorocytosine, cytosine, and pharmaceutical intermediates; Mainly covering the fields of antiviral, anti-tumor, and neurological medication. In terms of production management, the subsidiary companies of the group have passed the ISO9001 quality management system certification, achieving full process control from product design and development, raw material procurement, process control to product sales; In terms of raw material drug production, the subsidiary companies of the group implement GMP management, and multiple products have passed GMP certification.